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Abstract
Alteration of early haematopoietic development is thought to be responsible for the onset of immature leukemias and
lymphomas. We have previously demonstrated that TaxHTLV-1 interferes with ß-selection, an important checkpoint of early
thymopoiesis, indicating that human T-cell leukemia virus type 1 (HTLV-1) infection has the potential to perturb thymic
human ab T-cell development. To verify that inference and to clarify the impact of HTLV-1 infection on human T-cell
development, we investigated the in vivo effects of HTLV-1 infection in a ‘‘Human Immune System’’ (HIS) Rag2-/-cc
-/- mouse
model. These mice were infected with HTLV-1, at a time when the three main subpopulations of human thymocytes have
been detected. In all but two inoculated mice, the HTLV-1 provirus was found integrated in thymocytes; the proviral load
increased with the length of the infection period. In the HTLV-1-infected mice we observed alterations in human T-cell
development, the extent of which correlated with the proviral load. Thus, in the thymus of HTLV-1-infected HIS Rag2-/-cc-/-
mice, mature single-positive (SP) CD4+ and CD8+ cells were most numerous, at the expense of immature and double-
positive (DP) thymocytes. These SP cells also accumulated in the spleen. Human lymphocytes from thymus and spleen were
activated, as shown by the expression of CD25: this activation was correlated with the presence of tax mRNA and with
increased expression of NF-kB dependent genes such as bfl-1, an anti-apoptotic gene, in thymocytes. Finally, hepato-
splenomegaly, lymphadenopathy and lymphoma/thymoma, in which Tax was detected, were observed in HTLV-1-infected
mice, several months after HTLV-1 infection. These results demonstrate the potential of the HIS Rag2-/-cc
-/- animal model to
elucidate the initial steps of the leukemogenic process induced by HTLV-1.
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Introduction
HTLV-1 (Human T cell Leukaemia Virus, type 1), the only
retrovirus associated with a neoplastic disease in humans, is the
etiologic agent of Adult T-cell Leukaemia (ATL), an aggressive
clonal lymphoproliferative disorder of mature CD4+ CD25+ T
cells [1-3]. It is considered that HTLV-1 infection early in life
predisposes to ATL. Indeed, epidemiological studies have
stressed that ATL develops after an extremely long (several
decades) latency period, often in patients who were infected as
neonates through breastfeeding [4]. T-cell leukemias such as T-
ALL (T-cell acute lymphoblastic leukaemia) which mainly occur
in children and adolescents, are thought to result from malignant
thymocytes arising at defined stages of intrathymic T-cell
development [5,6]. Thus, HTLV-1 infection within the thymus
might be an essential event in the pathogenesis of ATL. In vitro,
HTLV-1 can productively infect human hematopoietic CD34+
progenitor cells as well as human immature thymocytes [7–9]. It
has also been demonstrated that reconstitution of T lymphopoi-
esis with HTLV-1-infected CD34+ cells in severe combined
immunodeficient (SCID) mice engrafted with human thymus
and liver tissues resulted in the alteration of thymopoiesis, as
shown by abnormalities in the size of thymocyte subpopulations
[7]. Recently, Banerjee et al. have generated a humanized model,
which partially recapitulates HTLV-1-induced T-cell leukemo-
genesis by inoculating immunodeficient mice with human
CD34+ hematopoietic progenitor cells infected ex vivo with
HTLV-1 [10].
HTLV-1 is a complex retrovirus that relies upon multiple
gene products to accomplish replication and disease. Among
them, Tax and HBZ are key regulatory proteins. HBZ, encoded
by the antisense strand of the HTLV-1 proviral DNA, is
permanently expressed and required for efficient viral infectivity
and persistence, whereas Tax has been shown to deregulate a
number of cellular genes leading to cellular proliferation, to
induce genetic instability, thus contributing to malignant
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progression [3]. Studies on Tax-transgenic mice that express tax
under the control of either the HTLV-1 LTR or alternative
promoters that target Tax expression to lymphocytes have
demonstrated that Tax can perturb lymphocyte functions. The
development of tumors in most of these transgenic mouse
models also provided evidence of the leukemogenic potential of
Tax. Interestingly, when the transgene expression was placed
under the control of the Lck promoter, which restricts Tax
expression to developing thymocytes, an ATL-like phenotype
developed in the transgenic mice [11]. These observations
suggest that the leukemogenic activity of Tax is related to T-cell
development in the thymus. We have previously reported that
Tax, by silencing E2A transcription factors, down-regulates the
expression of the pTa gene thus perturbing b-selection, the
early and critical checkpoint of human T-cell development in
the thymus [12,13]. These in vivo and in vitro studies indicated
that HTLV-1 infection in the thymus might be a prerequisite for
the malignant lymphoproliferation associated with this retroviral
infection.
In the present study, we first investigated the in vivo effects of
HTLV-1 infection on human T-cell development in ‘‘Human
Immune System’’ (HIS) mice by transplanting human CD34+ cord
blood cells into conditioned newborn BALB/c Rag2-/-cc
-/-
recipient mice. The resulting HIS mice were infected with
HTLV-1, at a time when the successive stages of the abT-cell
development are evident in the thymus of these mice. In the
HTLV-1-infected Rag2-/-cc
-/- mice, we observed efficient viral
expression and profound alterations in human thymopoiesis, as
shown by the accumulation of activated mature single-positive
CD4+ and CD8+ lymphocytes in the thymus and in the spleen.
The role of Tax in that process is indicated by an increased
expression of NF-kB-dependent genes such as CD25 and Bfl-1 in
thymocytes of these mice. In addition, abnormalities frequently
observed in ATL such as hepatosplenomegaly, lymphadenopathy
and lymphoma were detected in HTLV-1-infected mice, several
months after HTLV-1 infection. This HIS Rag2-/-cc
-/- animal
model might be of great interest to decipher the initial steps of the
leukemogenic process induced by HTLV-1.
Results
HIS Rag2-/-cc
-/- mice were generated by intrahepatic transplan-
tation of human CD34+ cord blood cells into sublethally irradiated
immunocompromised newborn BALB/c Rag2-/-cc
-/- mice [14-16].
We first analyzed by flow cytometry the expression of CD4 and
CD8 on human CD45+ (hu-CD45) cells in the thymus of HIS
Rag2-/-cc
-/- mice transplanted with CD34+ cells. Five weeks after
transplantation, immature CD3- thymocytes, including the double-
negative (DN) CD4-CD8- cells, the CD4+ immature single-positive
(CD4ISP) cells and the double-positive (DP) CD4+CD8+cells were
found to be predominant, whereas a low percentage of mature
CD3+ T-cells containing DP cells and single-positive (SP) CD4+ or
CD8+ cells was detected. pTa has been shown to be highly
expressed in immature thymocytes and more specially in CD4ISP
cells, just before the pre-T-cell Receptor complex formation
[17,18]. Eight weeks after transplantation, the population of mature
thymocytes predominated over that of immature thymocytes,
indicating that human abT-cell development was completed in
the thymus of transplanted HIS Rag2-/-cc
-/- mice (Figure 1A). At
that time, approximately 90% of the cells present in the thymus of
the HIS Rag2-/-cc
-/- mice expressed hu-CD45+. Circulating human
mature T cells were also detected in the blood and secondary
lymphoid organs (Figure 1B). Thus, mature T cells represented
about 17% of the hu-CD45+ cells in the spleen, 10 weeks after
CD34+ transplantation (Figure 1C). These observations are in line
with those previously published [16] and confirm that the successive
maturational steps of human abT-cell development were completed
in the thymus of these mice within two months following human
CD34+ inoculation.
Evaluation of proviral load in HTLV-1-infected HIS
Rag2-/-cc
-/- mice
Taking into account the chronology of the different matura-
tional stages of human abT-cell development in the thymus of HIS
Rag2-/-cc
-/- mice, HTLV-1 infection of these mice was carried out
between 4 and 8 weeks after CD34+ transplantation. The mice
were inoculated intraperitoneally either with 26106 lethally
irradiated HTLV-1-producing MT2 cells in Phosphate Buffered
Saline (PBS) or with PBS only (mock-infected) (Figure 2A). In
parallel, untransplanted BALB/c Rag2-/-cc
-/- mice were inoculat-
ed with lethally irradiated MT2 cells.
Autopsy examination between 10 and 35 weeks after HTLV-1
inoculation revealed a significant increase of the size of the
thymus, the spleen and lymph nodes of HIS Rag2-/-cc
-/- mice
inoculated with MT2 cells, when compared to those of mock-
infected animals. Furthermore tumor-like nodules were frequently
observed in the spleen and the liver of MT2-inoculated mice
(Figure 2B).
To ascertain that the MT2-inoculated HIS Rag2-/-cc
-/- mice
were indeed infected, we used ALU-PCR to amplify gagHTLV-1
sequences from human DNA isolated from splenocytes. The
results showed that all but two MT2-inoculated HIS Rag2-/-cc
-/-
mice were HTLV-1-infected (Figure 2C, lanes 3, 4 and Figure 2D,
lane 3). As expected, viral sequences were not observed in mock-
infected HIS Rag2-/-cc
-/- mice (Figure 2C lanes 1, 2 and
Figure 2D, lane 2). Likewise, they were not detected in MT2-
inoculated BALB/c Rag2-/-cc
-/- mice, thus excluding the possi-
bility that the inoculated irradiated MT2 cells were still present in
these mice (Figure 2D, lane 1).
The HTLV-1 proviral load (PVL) in HTLV-1-infected HIS
Rag2-/-cc
-/- mice was then evaluated by quantitative PCR (qPCR).
An increase in the PVL was observed, which correlated with the
length of the infection period (Figure 3A). Indeed, a PVL value in
Author Summary
Human T-cell leukemia virus type 1 (HTLV-1) is a retrovirus
responsible for the development of Adult T cell Leukemia,
an aggressive malignant lymphoproliferation that occurs
several decades after viral exposure in some individuals
infected when neonates via breastfeeding. Here, we used
mice that were humanized by transplantation of human
hematopoietic stem cells isolated from cord blood. Such
an animal model may reproduce key aspects of in vivo
infection with HTLV-1 and improve the understanding of
the early steps of the leukemogenic process. These
humanized mice when inoculated with HTLV-1 were
indeed productively infected, as shown by the detection
and the expression of the provirus in human cells. We
observed that T-cell development in the thymus of these
mice was profoundly altered, as ascertained by the
increased proliferation of activated mature T lymphocytes
that accumulated in the thymus as well as in the spleen.
These alterations of human thymic T-cell development
may be linked to the development of ATL–like pathologies.
These results show that this humanized mouse model
provides an invaluable tool not only to study the early
stages of the infection leading to the development of
malignant lymphoproliferations, but also to design new
therapeutic approaches.
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the range of 10 to 103 copies per 105 human cells was found in 20
mice that were sacrificed between 5 and 20 weeks after inoculation
of MT2 cells. These mice were subsequently referred to as low-
PVL mice. Fifteen mice that were sacrificed between 16 and 35
weeks had a PVL between 103 to 106 copies per 105 cells; these
were referred to as high-PVL mice. The low PVL values (median
8.96102 copies/105 cells) were similar to those in healthy human
HTLV-1 carriers, whereas the high PVL values (median 1.16105
copies/105 cells) were similar to those in ATL cells [19]. These
results show that HTLV-1 infection of human immune cells was
established in the HIS Rag2-/-cc
-/- mice and that the PVL
correlated with the length of the infection period (r2 = 0.9704).
We then quantified cellular clonality in the spleen of five
representative HTLV-1 infected HIS Rag2-/-cc
-/- mice, by
measuring the frequency of the different HTLV-1 infected clones
present in that organ. The calculation of the oligoclonality index is
shown in Figure 3B. Each slice in the pie chart represents a single
Unique Insertion Site (UIS) and the size of the slice is proportional
to the relative abundance of that UIS. In the mouse with the
lowest oligoclonality index (0.45), the slices of the pie chart are of
similar size. In contrast, in the two mice with the highest clonality
index (0.71 and 0.79), two clones were found to predominate.
Although there was no significant correlation between the
oligoclonality index and the proviral load, these data indicate
that oligoclonal proliferation of infected cells occurred in these
mice, as observed in naturally infected patients [20].
The abT-cell development in HTLV-1 infected HIS
Rag2-/-cc
-/- mice is altered in a PVL-dependent manner
To investigate the effect of HTLV-1 infection on abT cell
development in HIS Rag2-/-cc
-/- mice, we proceeded to a
comparative FACS analysis of thymopoiesis in infected or in
mock-infected mice. In the latter, at either 8 to 20 weeks (early) or
18 to 35 weeks (late) after PBS injection, the relative frequency of
the three main human subpopulations (immature, DP and SP)
remained mostly unchanged (Figure 4A). In the low-PVL HTLV-
1-infected HIS Rag2-/-cc
-/- mice, the respective percentages of
these subpopulations were slightly different with a higher
frequency of DP cells and a lower frequency of SP cells
(Figure 4B). In contrast, in the high-PVL mice, a significant
Figure 1. Human hematopoietic cell engraftment and T-cell development in HIS Rag2-/-cc
-/- mice. (A) Efficient intrathymic de novo
development of human T-cells in BALB/c Rag2-/-cc
-/- mice. Animals were sacrificed at 5 and 8 weeks after CD34+ cell transplantation. The flow
cytometry dot plots show representative examples of staining for human CD3, CD4 and CD8 markers (values on the dot plots are for the frequency of
the corresponding populations). (B) Frequency of human CD45+ cells in bone marrow, spleen, thymus and peripheral blood in HIS Rag2-/-cc
-/- mice, at
10 to 30 weeks post transplantation. (C) Representative flow cytometry analysis of total splenocytes in transplanted mice sacrificed at 7 weeks after
transplantation stained for human CD4 and CD8 lymphoid cell surface markers.
doi:10.1371/journal.ppat.1002231.g001
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depletion of the immature DN subpopulation was observed
together with a strong decrease of DP thymocytes and with a
large increase of the mature SP cells. Such alterations were evident
in mice as young as 18 weeks, i.e. 13 weeks after inoculation with
MT2 cells. These data show that the main impact of HTLV-1
infection was on the population of the most immature T cells, as
indicated by their significant decrease in mice with the highest
PVL. In the spleen of infected mice, the population of mature T
cells increased with the PVL level to the point where mature T
cells were the only human population observed in that organ
(Figure 4C).
These observations suggested a positive correlation between the
PVL and the alterations of human T cell development observed in
HTLV-1-infected HIS Rag2-/-cc
-/-mice. To verify this suggestion,
we analysed CD4 and CD8 expression on thymocytes of either the
less mature CD3- or the more mature CD3+ subpopulations of
four age-matched mice including one mock-infected mouse and
three HTLV-1-infected mice, one with a low PVL and two with
high PVL (Figure 4D). We observed a significant decrease in the
CD3- subset, which correlated with the increase in PVL. In fact,
the immature DN, CD4ISP and DP subpopulations were severely
depleted in the mouse with the highest PVL (left panel), whereas
the CD3+ SP cells increased to 78.3% in the same mouse (right
panel). The thymocyte subpopulations in three mice with a
comparable high PVL, but killed at different times after infection
(20, 23 and 35 weeks) displayed a similar profile, i.e. depletion of
CD3- immature and DP cells and increase of CD3+ mature SP
cells (Figure 4E). These results show that HTLV-1 infection led to
an increased number of mature T cells in the thymus and in the
periphery. We conclude that HTLV-1 infection perturbed the
development of abT lymphocytes in the thymus of HIS
Rag2-/-cc
-/- mice, mainly by propelling immature thymocytes
Figure 2. Integration of the HTLV-1 provirus in the genome of human cells in HTLV-1-infected HIS Rag2-/-cc
-/- mice. (A) Schematic
representation of the experimental infection set-up. Four to eight weeks after CD34+ cell transplantation, the animals were intraperitoneally
inoculated with 26106 lethally irradiated MT2 cells in 100 ml PBS or with PBS alone for the mock-infected mice. Animals were sacrificed and analyzed
between 8 and 36 weeks after CD34+ cell transplantation. (B) Presence of disseminated tumors in HTLV-1 infected HIS Rag2-/-cc
-/- mice, sacrificed
between 16 and 35 weeks after infection and referred to as high proviral load (PVL) mice. Infection resulted in thymoma, and splenomegaly and
HTLV-1 positive lymphomas in spleen, in mesenteric lymph nodes or in liver (arrows). Are also shown representative photographs of thymus, spleen,
lymph node and liver of 34-week-old HIS Rag2-/-cc
-/- control mice. Bars, 10 mm (C) ALU-PCR was carried out on the DNA extracted from the thymus of
mock-infected (lanes 1 and 2) and infected (lanes 3 and 4) mice. The lower panel (two-rounds of PCR, the first one with ALU primers and the second
with gag primers) indicates that the HTLV-1 gag gene is integrated in the human genome. The upper panel shows the result of control PCR for gag
carried out on the initial diluted samples without any ALU-PCR. (D) HTLV-1 integration does not occur in the mouse genome: PCR for mouse and
human actin and for gag were performed with the DNA extracted from the spleen of Rag2-/-cc
-/- mice (not inoculated with human CD34+ cells),
infected with HTLV-1 (lane 1), or HIS Rag2-/-cc
-/- mice either mock-infected (lane 2) or infected with HTLV-1 (lane 3).
doi:10.1371/journal.ppat.1002231.g002
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towards the late stages of maturation. We now propose to
investigate whether such an effect is induced by the viral
regulatory Tax.
Activation of survival and proliferating pathways in HTLV-
1-infected HIS Rag2-/-cc
-/- mice
Of the 35 HIS Rag2-/-cc
-/- mice that were inoculated with
HTLV-1-producing MT2 cells, 13 mice displayed pathological
features, the severity of which appeared to correlate with proviral
load and with the number of activated CD25+ T-cells in the
thymus (Table 1). These pathological features were observed only
in high-PVL mice that were killed between 16 and 35 weeks
(Figure 5A). While most of these mice only displayed enlarged
lymph nodes, some of them also developed hepatosplenomegaly,
lymphadenopathy, and thymoma (compare panel 2 to panel 1) in
which the cells were found to express the Tax protein detected by
immunohistochemical analysis (panels 5,6,8,9).
Based on our previous experiments on human immature
thymocytes, these in vivo observations therefore suggested that
Tax induced the alterations in thymopoiesis observed in HIS
Rag2-/-cc
-/- mice. tax transcription was readily detected in the
thymus of high-PVL mice, whereas in the low-PVL mice, it was
very low or undetectable (Figure 5B). hbz transcription displayed
the same pattern (Figure 5C). Finally, the observed increase in Tax
transcription correlated with proviral load, unlike HBZ transcripts
(Figure 5D).
We previously reported that Tax protein interferes with
assembly of the pre-TCR when expressed in vitro in human
immature thymocytes, such as the CD4ISP thymocytes [12,13].
During normal abT-cell development, signals from the pre-TCR
activate the NF-kB pathways that control the expression of target
genes implicated in cell proliferation and survival [17]. We
hypothesized that Tax might compensate for the absence of a
functional pre-TCR by inducing NF-kB activation in immature
thymocytes. We therefore investigated the impact of Tax
Figure 3. Proviral load and clonality in HTLV-1-infected HIS Rag2-/-cc
-/- mice. (A) Temporal evolution of proviral load (PVL) in the thymus.
The HTLV-1 PVL (representing the copy number of tax per 105 human cells) were determined by quantitative real-time PCR at the indicated times
after CD34+ cell transplantation. The PVL level correlates with the length of the infection period (r2 = 0.9704). Samples were analyzed at least in
duplicate; on all graphs, one dot represents one individual HIS Rag2-/-cc
-/- mouse. (B) Clone frequency distribution of HTLV-1 infected cells in the
spleen from 5 different mice. The HTLV-1 clonal structure in each genomic DNA sample is depicted by a pie chart. Each slice represents one unique
insertion site (clone); the size of the slice is proportional to the relative abundance of that clone. The 3 most abundant clones were colored in red/
orange in each spleen sample. The total number of detected clones was given together with the oligoclonality index values calculated as described in
[20].
doi:10.1371/journal.ppat.1002231.g003
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overexpression on the transcription of NF-kB-related genes
(RelA/p65, p105/p50, c-Rel) in immature thymocytes. We
observed that the amount of the respective transcripts was much
greater in TaxGFP-expressing immature thymocytes than in GFP+
control cells (Figure 6A). We also analysed isolated mRNAs to
detect transcripts of the anti-apoptotic genes Bfl-1 and Bcl-2,
Figure 4. The human T-cell development is altered in HTLV-1-infected HIS Rag2-/-cc
-/- mice. (A) Composite data from 11 mock-infected
mice sacrificed early after CD34+ cell transplantation (early) and 6 mock-infected mice sacrificed later on (late). Bar graphs represent percent of human
CD45+ thymocytes that are CD4-CD8- and CD4ISP immature cells (light grey), DP cells (dark grey) and SP cells (black). The graphs present the mean
and the SD. Statistical differences were calculated using the x2 test: *P,0.05, **P,0.01. (B) Composite data from 20 HTLV-1-infected mice with a low
PVL and 15 HTLV-1-infected mice with a high PVL showing a decrease in the frequency of the immature thymocytes (light grey) concomitant with an
increase of that of the mature SP cells (black) in high PVL mice. (C) Expansion of human CD3+ T-cells at the periphery after HTLV-1 infection: FACS
analysis of CD3 expression by hCD45+ splenocytes in 35 HIS Rag2-/-cc
-/- either mock- or HTLV-1-infected mice. The median values are indicated by
horizontal lines. Statistical differences were calculated using the Mann-Whitney’s U test: *P,0.05, ***P,0.001, ****P,0.0001. (D) Correlation between
HTLV-1 proviral load, the depletion of immature thymocytes and the expansion of mature thymocytes. FACS plots of the immature CD3-
subpopulations containing DN (CD4-CD8-), immature DP and CD4ISP and the mature CD3+ subpopulations, stained for human CD4 and CD8 are
shown for representative animals either mock-infected or HTLV-1-infected with different PVL (indicated on the right side) and killed at 20 weeks after
CD34+ cell transplantation. (E) The alteration of the human thymopoiesis induced by HTLV-1 is independent on the duration of the infection period:
FACS analysis of the human CD3- and CD3+ thymocyte subpopulations in three HTLV-1-infected mice sacrificed at different weeks after CD34+ cell
transplantation, but each with a similar high PVL (from 5.66104 to 6.76104 copies/105 cells).
doi:10.1371/journal.ppat.1002231.g004
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because Bfl-1 is a target of NF-kB transcriptional activity whereas
Bcl-2 is independent of NF-kB. Only the expression of Bfl-1 was
significantly increased in Tax-expressing thymocytes (Figure 6B).
These results show that Tax expressed in human immature
thymocytes activates the transcription of NF-kB factors and that of
the Bfl-1 anti-apoptotic gene.
We therefore investigated whether the NF-kB dependent
expression of these two genes, bcl2 and bfl1, was increased in
HTLV-1-infected HIS Rag2-/-cc
-/- mice. RT-qPCR analysis
showed a clear increase in the transcription of Bfl-1 in these mice,
when compared to control animals (Figure 6C); this increase was
comparable to that found in Tax-expressing thymocytes
(Figure 6B). The increase in Bfl-1 mRNA correlated with that of
tax mRNA, as did CD25 mRNA, which is also dependent on NF-
kB factors. Indeed, a comparative FACS analysis of mock-infected
and HTLV-1 infected HIS Rag2-/-cc
-/- mice indicated that the
number of hu-CD45+ CD25+ cells in the thymus and in the spleen
cells was significantly higher in high PVL mice than in low PVL or
in control mice (Figure 7A, B, C). Lastly, activated T lymphocytes,
which were mainly CD4+, were also found in the peripheral blood
of an HTLV-1-infected HIS Rag2-/-cc
-/- mouse (Figure 7D). This
finding demonstrates that HTLV-1 infection induced expansion of
mature T-cells in the periphery. We conclude that Tax activates
the transcription of genes involved in cell survival and proliferation
in the thymus of HTLV-1–infected HIS Rag2-/-cc
-/- mice and
favours the expansion of mature activated T cells. Thus, the
presence of T-cell proliferation in HTLV-1 infected HIS
Rag2-/-cc
-/- mice indicates that HTLV-1 infection of the thymus
might be a critical pre-leukemogenic event.
Discussion
During the last decade, humanized mouse technology has made
remarkably rapid progress, allowing the establishment of high
levels of human chimerism in various host organ/tissues,
particularly the immune system, liver and muscle [14,21–23].
These humanized mice appear ideally suited for direct investiga-
tion of human infectious agents [24,25]. In the present study, we
have used Rag2-/-cc
-/- mice, which recapitulate the main events in
the development of the human lymphoid compartment [26–28].
These mice have already displayed interesting potential for
studying infection with lymphotropic viruses, such as HIV
(Human Immunodeficiency Virus) and EBV (Epstein-Barr Virus)
[29–34].
In the present study, we used HIS Rag2-/-cc
-/- mice inoculated
with irradiated HTLV-1-producing cells, at a time when the
human lymphoid compartment has been established, i.e. within a
period of 1 to 2 months after transplanting BALB/c Rag2-/-cc
-/-
immunodeficient animals with human CD34+ cord blood cells.
This infection protocol was found to be very efficient, as in most of
the inoculated HIS Rag2-/-cc
-/- mice the provirus was found
integrated in the genome of human cells. These mice were
analyzed at regular intervals within a 7-month period after
inoculation. We observe a sequential increase of the proviral load,
which correlated with the appearance of critical alterations in the
distribution of T-cell subsets in the chimeric thymus. Specifically,
we observed slight differences in the respective percentages of the
three main thymocyte subsets (immature, DP and SP) between
HIS Rag2-/-cc
-/- mice with a low proviral load and mock-infected
animals. Conversely, in mice with a high proviral load, the SP cells
predominated at the expense of the immature and DP popula-
tions. These data provide strong evidence that in vivo HTLV-1
infection of HIS Rag2-/-cc
-/- mice perturbs human T-cell
development in the thymus at the level of immature cells, by
propelling development towards the mature stages. In addition,
the infected mice had a high proviral load in the same range as
that found in ATL patients [19]. These findings demonstrate that
HIS Rag2-/-cc
-/- mice infected with HTLV-1 provide a suitable
model for viral-induced malignancy. They further suggest that the
combination of immature target cells in the thymus and the
immunodeficient environment of HIS Rag2-/-cc
-/- mice favours
the rapid development of a T-cell malignancy.
Table 1. Pathological features in HIS Rag2-/-cc
-/- mice infected with HTLV-1.
Mouse* Age of Infection Age of Analysis Proviral Load 6 observations
#209 7 wk 28 wk 1.586103
#178 5 wk 18 wk 5.396103 Enlarged LN
#365 5 wk 21 wk 1.056104 Enlarged LN
#273 4 wk 20 wk 1.656104 Enlarged LN DP T cells in blood, spleen and Bone marrow
#189 4 wk 16 wk 3.426104 Enlarged LN
#297 7 wk 32 wk 4.756104
#357 5 wk 23 wk 7.306104 Enlarged LN Tumor in the liver Leukemia
#248 7 wk 20 wk 8.126104
#240 7 wk 23 wk 9.376104 Enlarged LN Tumor in the liver and the spleen
#307 7 wk 32 wk 9.746104
#242 7 wk 20 wk 1.156105 Enlarged LN
#279 7 wk 35 wk 1.236105 Enlarged LN Thymoma
#200 8 wk 29 wk 1.466105
#278 7 wk 33 wk 2.126105 Enlarged LN Tumor in the spleen
#190 4 wk 18 wk 9.786105 Thymoma
#188 4 wk 30 wk 1.046106 Enlarged LN Thymoma
*Mice were inoculated intraperitoneally with irradiated MT2 cells.
u Proviral Load is expressed as number of proviral copies per 105 thymocytes.
doi:10.1371/journal.ppat.1002231.t001
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This model will also be helpful for studying the involvement of
other HTLV-1 genes like hbz in viral pathogenesis as well as the
role of the proviral integration sites. Thus, an oligoclonal
expansion of HTLV-1-infected cells was observed in the periphery
of five infected HIS Rag2-/-cc
-/- mice. In contrast, preliminary
results obtained from one HTLV-1 infected mouse displaying a
thymoma indicate an extraordinary degree of polyclonality of
integration sites in the thymus (Figure S1A). Interestingly, the
three clones that dominated the population in both spleen and
lymph nodes were not dominant in the thymus, and the three most
abundant clones observed in the thymus were not detected in the
periphery (Figure S1A, B, C).
Our observations are consistent with those reported by Banerjee
et al. who used a different infection strategy as well as different
immunodeficient mice [10]. Indeed, these authors generated
HTLV-1-infected humanized nonobese diabetic severe combined
immunodeficiency (HU-NOD/SCID) mice by inoculating 4- to-
6-week NOD/SCID mice with human fetal liver-derived CD34+
cells infected ex vivo with HTLV-1. Less than half of these infected
mice developed T-cell lymphomas with a CD4+CD25low or
CD4+CD25low phenotype. These mice also showed greater
proliferation of infected human CD34+ cells in the bone marrow,
leading the authors to propose that HTLV-1 can transform
CD34+ cells. However, HTLV-1 proviral sequences were not
detected in CD34+ bone marrow cells from ATL patients [35].
Banerjee et al. also reported that HTLV-1 infection skewed T-cell
development in the thymus of these HTLV-1-infected HU-NOD/
SCID mice, as well as in the thymus of HTLV-1-infected HU-
NSG (NOD/SCID IL-2c chainnull) mice. These data support our
present observations which suggest that alterations of T-cell
development play a prominent role in the initiation of HTLV-1-
induced leukemogenesis.
Figure 5. Expression of Tax and HBZ in thymocytes isolated from HTLV-1-infected HIS Rag2-/-cc
-/- mice. (A) Immunohistological
characterization of representative sections of thymus and spleen from HTLV-1- and mock-infected HIS mice. The thymus of control mice (1) shows a
normal architecture, whereas that of HTLV-1-infected mice contains a dense cellular infiltrate made of large lymphoid cells interspersed with giant
multinucleated cells (2). A disorganized architecture is also observed in the infected spleen; the white pulp is hyperplastic and is made of large
lymphoid aggregates containing large lymphoid cells and multinucleate cells; the red pulp shows extramedullary hematopoiesis with myeloid and
erythroid elements (3). Tax immunostaining reveals that the thymus and spleen of infected animals displayed large lymphoma cells with a nuclear
localization of Tax (5,6,8,9). Infiltration of lymphomatous cells expressing Tax was not observed in control mice (4,7). (B-C) Tax and HBZ mRNA loads
in thymocytes isolated from HTLV-1-infected HIS Rag2-/-cc
-/- mice. Total RNAs were extracted from thymocytes of infected mice with either a low or a
high PVL, and levels of mRNA coding for Tax and HBZ were measured by RT-qPCR and normalized to b-actin. The zero value of Tax and HBZ gene
transcripts was observed in 60 and 100% of mice with low PVL, respectively; the median values are indicated by horizontal lines. (D) Dot plot graph of
Tax and HBZ mRNA loads as a function of the proviral load.
doi:10.1371/journal.ppat.1002231.g005
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In a previous study, we demonstrated that the viral Tax
regulatory protein can inactivate the activity of bHLH E2A
transcription factors [12]. This inhibitory effect leads to a decrease
of the transcription of the pTa gene in immature thymocytes, thus
precluding the assembly of the pre-TCR and interfering with the b-
selection checkpoint [13]. The pre-TCR plays a crucial role in T-
cell development, by allowing the maturation of thymocytes with a
functional b chain. Signalling from the pre-TCR in the b-selected
cells leads to the activation of NF-kB, which provides survival and
proliferative advantages [18,36]. We hypothesize that Tax, which is
able to activate the NF-kB pathways, compensates for the absence
of the pre-TCR in HTLV-1-infected immature thymocytes. Thus,
Tax-activated NF-kB would prevent apoptosis and drive prolifer-
ation. We indeed observed that activated transcription of the NF-kB
pathways in ex vivo Tax-expressing immature thymocytes correlated
with increased transcription of Bfl1, an anti-apoptotic NF-kB-
responsive gene. Likewise, we found increased transcription of Bfl-1
in thymocytes of infected mice. We also observed an expansion of
mature SP cells in the thymus and in the spleen of HTLV-1-infected
HIS Rag2-/-cc
-/-, and an increase in the percentage of CD25+CD4+
T-cells. Finally, pathological features observed in some of these mice
might be related to the disturbances of the abT-cell development
induced by HTLV-1 infection.
We conclude that HTLV-1 infection can override the pre-TCR
checkpoint by forcing immature thymocytes to progress towards a
more differentiated phenotype (acquisition of CD4 and CD8) in
the absence of the pre-TCR. The Tax protein may play a key part
in this process. The observed disturbances of thymopoiesis caused
by HTLV-1 infection may represent critical events in the initiation
of the leukemogenic process associated with this retroviral
infection. More specifically, they underline the relationships
between dysregulated T-cell development and neoplastic transfor-
mation and provide another contribution to the identification of
molecular and cellular mechanisms involved in leukaemogenesis
[37]. Indeed, the constitutive expression of Tax in immature
thymocytes at the level of the b-selection checkpoint alters the
developmentally regulated interplay between pre-TCR signalling
and E2A activities, resulting in leukemia/lymphoma promotion.
HTLV-1-associated T-cell leukaemia strongly resembles the
Notch3-induced T-cell malignancies in several respects [38].
Notch3, a member of the Notch family, is known to play a critical
role in T-cell development and its constitutive activation has been
related to T-cell leukaemia in both animal models and human
diseases. The development of the T-cell leukaemogenic process
requires the combined expression of Notch3 and the pre-TCR
linked to a sustained down-regulation of E2A activity [37]. It is
noteworthy that in the absence of the pre-TCR, Notch3, like Tax,
can force immature T-cells through otherwise pre-TCR-depen-
dent developmental stages and favour the progression toward a
more differentiated phenotype by acquisition of CD4 and CD8. In
contrast with Notch3, Tax is able to activate both the alternative
and canonical NF-kB pathways, implying that the appearance of
lymphoid tumors in HTLV-1 infected is linked to the exclusive
activity of Tax. However, even if Tax down-modulates the
Figure 6. Enhanced transcription of the NF-kB and the antiapoptotic Bfl1 genes by Tax. (A-B) Immature thymocytes isolated as previously
described [12] were nucleofected with either pCMV-TaxGFP or pCMV-GFP. Twenty-four hours later, GFP+ cells were sorted, and the total RNAs were
isolated and reverse transcribed. The cDNA samples were subjected to qPCR using primers specific for the indicated genes and normalized for the
amount of cDNA, using human b-actin as an internal control. Standard deviations are from at least two determinations performed in triplicate.
* P,0.05 by Mann-Whitney U test. (C) In vivo correlation between the Bfl1 gene transcription and the HTLV-1 proviral load: total RNAs were extracted
from thymocytes of HTLV-1-infected HIS Rag2-/-cc
-/- mice from each group, and levels of bfl-1 and bcl-2 mRNAs normalized to human b-actin were
measured by RT-qPCR. Levels of bfl-1 mRNAs were significantly higher in high PVL mice than in low PVL mice, whereas bcl-2 transcription was
unchanged. The median values are indicated by horizontal lines. * P,0.05 using the Mann-Whitney U test.
doi:10.1371/journal.ppat.1002231.g006
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transcription of pTa, leukemogenesis may also require continued
weak expression of the pre-TCR, which cooperates with pTa to
reach a critical level of NF-kB activation. Future experiments
should be performed to verify that hypothesis.
In conclusion, our study demonstrates that BALB/c Rag2-/-cc
-/-
mice transplanted with human CD34+ cord blood cells provides an
in vivo model to define the early steps of HTLV-1 infection that
might lead to a better understanding of the initiation of the
HTLV-1 associated leukemia. Our observations provide evidence
that HTLV-1 infection in the thymus propels infected thymocytes
toward the mature stages of T-cell development and favours the
activation and the proliferation of these cells, thus providing a
substrate population for further altered gene expression that would
allow the emergence of a malignant clone.
Materials and Methods
Ethics statement
Umbilical cord blood was obtained from healthy full-term
newborns with written parental informed consent according to the
guidelines of the medical and ethical committees of Hospices Civils
de Lyon and of Agence de Biome´decine, Paris, France.
Experiments using cord blood were approved by both committees
and were performed in full compliance with French law.
Animal experimentation was performed in strict accordance
with the French ‘‘Comite´ National de Re´flexion Ethique sur
l’Expe´rimentation Animale, nu15’’ and the ethical guidelines for
the care of these mice of the Plateau de Biologie Experimentale de
la Souris (PBES, UMS 3444) at Ecole Normale Supe´rieure de
Lyon. The protocol used throughout that study was approved by
the Committee on the Ethics of Animal Experiments of the Ecole
Normale Supe´rieure de Lyon (Permit number: 0231). All efforts
were made to minimize animal suffering.
Isolation of human CD34+ cells from cord blood samples
After density gradient centrifugation of human cord blood,
CD34+ cells were enriched twice using immunomagnetic beads
according to the manufacturer instructions (CD34+ MicroBead
Kit, Miltenyi Biotec, Bergisch-Gladbach, Germany). Purity
($95%) was evaluated by FACS analysis using human CD34,
CD3 and CD19 antibodies. Cells were either frozen or
immediately transplanted when newborn mice were available.
Generation of HIS Rag2-/-cc
-/- mice
Rag2-/-cc
-/- mice on a BALB/c background were bred and
maintained under specific pathogen-free conditions in accordance
with the French law and the guidelines of PBES. Rag2-/-cc
-/- mice
were transplanted with human CD34+ cells, as previously
described [16,39]. Briefly, newborn (less than 3-day old) mice
were irradiated twice within a 3-hour interval with 262 Gy from a
137Cs source (CIS BIO international, IBL 637) at 1.28 Gy/min., a
dose that was adjusted to be sub-lethal. After the second
irradiation, mice were injected intrahepatically with 26105 human
CD34+ cord blood cells in 30 ml PBS.
HTLV-1 infection of HIS Rag2-/-cc
-/- mice
The HTLV-1 T-cell line MT2 [40] was irradiated with 77 Gy
from a 137Cs source (CIS BIO international, IBL 637) at 1.28 Gy/
min. This dose was adjusted to inhibit cell proliferation but not
HTLV-1 production. HIS Rag2-/-cc
-/- mice aged from 4 to 8
weeks were intraperitoneally injected with 26106 lethally irradi-
ated MT2 cells in 100 ml PBS. Mock-infected mice were injected
with PBS alone. Mice were sacrificed at different time-points after
infection. Infection was performed in a Biosafety Level 3
laboratory in accordance with the PBES guidelines.
Histopathological analysis
Anesthetized mice were killed and tissue specimens (thymus,
spleen, bone marrow and lymph nodes) were fixed directly in
neutral buffered formaldehyde, embedded in paraffin, sectioned
and stained with H&E solution. An indirect immunoperoxidase
technique was applied to 4 mm-thick formalin-fixed, paraffin-
embedded tissue sections with a rabbit polyclonal anti-Tax
antibody. An automated immunostainer was used (Ventana,
Tucson, AZ, USA). Antigen unmasking and immunodetection
were performed according to the manufacturer’s instructions
(Ventana). The avidin-biotin technique was used for development.
Flow cytometric analysis
Peripheral blood cells were collected from the retro-orbital
venous sinus under Ketamine-Xylazyne anesthesia. When needed,
mice were sacrificed after anesthesia and thymus, spleen, bone
marrow and lymph nodes were collected, gently minced in PBS to
Figure 7. Correlation between expression of CD25 activation
marker and HTLV-1 proviral load. (A) Representative flow
cytometry plots showing the expression of human CD25 and CD4
markers on thymocytes of 17 mock- and 35 HTLV-1-infected HIS
Rag2-/-cc
-/- mice with different PVL (indicated on top). (B) Frequency of
human CD4+ cells expressing CD25 among human thymocytes of 35
HIS Rag2-/-cc
-/- HTLV-1-infected mice; the median values are indicated
by horizontal lines. (C) Frequency of human CD4+ cells expressing CD25
among human splenocytes of 35 HIS Rag2-/-cc
-/- mice; the median
values are indicated by horizontal lines. Statistical differences were
calculated using the Mann-Whitney U test: **P,0.01, ***P,0.001,
****P,0.0001. (D) Lymphoproliferation in the peripheral blood of one
HTLV-1-infected HIS Rag2-/-cc
-/- mouse with a high PVL (7.36104 copies/
105 cells): this flow cytometry analysis shows that among the 85.6% of
huCD45+ cells (left panel), 97.2% are activated T lymphocytes (center
panel), the majority with a CD4+ phenotype (right panel).
doi:10.1371/journal.ppat.1002231.g007
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obtain a single-cell suspension. For FACS analysis, monoclonal
antibodies, conjugated with either FITC, PE, PE-Cy7, APC or
V450 against the following human antigens were used: CD4
(RPA-T4), CD8 (RPA-T8), CD19 (HIB19), CD34 (581/CD34),
CD45 (HI30), (all BD Biosciences, San Diego, CA), CD3
(UCHT1) and CD25 (BC96) (eBioscience, San Diego, USA).
Flow cytometric analysis was performed using a FACScanto II and
Diva for acquisition (Becton Dickinson Immunocytometry Sys-
tems, Mountain View, CA) and FlowJo (Treestar, Ashland, OR)
for data analysis.
DNA and RNA isolation
Genomic DNA was extracted from the single cell suspension
using the Nucleospin Blood kit (Macherey-Nagel, Du¨ren, Ger-
many) according to the manufacturer’s instructions, and resus-
pended in 60 ml of the supplied elution buffer. For mouse tissues,
RNA was extracted from the single cell suspension using the
Nucleospin RNA XS kit (Macherey-Nagel, Du¨ren, Germany)
according to the manufacturer’s instructions, and resuspended in
10 ml of water. For human thymus, total RNA was extracted from
1–26105 thymocytes using TRIzol reagent (Invitrogen) according
to the manufacturer’s instructions. Two chloroform extractions
were performed on the organic phase to avoid phenol contam-
ination. Before reverse transcription, RNAs were first treated with
10 U of RNase-free DNase I (Qiagen) for 20 min at 27uC and
then for 15 min at 60uC.
PCR, RT-PCR and quantitative real-time PCR (qPCR)
The RNA samples were reverse transcribed at 42uC for 1 hour
in a total volume of 20 ml reaction buffer containing 100 U of
SuperScriptTII Rnase H- reverse transcriptase (RT; Invitrogen). A
reaction without RT was performed in parallel to serve as control
for the absence of DNA contamination. PCR was performed using
the Phusion enzyme (Finnzyme, Espoo, Finland) in a Piko
thermocycler (Finnzyme, Espoo, Finland). For ALU-PCR, the
first round was carried out using an ALU-specific primer and a gag
specific primer (see sequence below). The amplification product
was then diluted in water (1/50) and used as templates for a gag-
specific PCR. The control PCR for gag was carried out by diluting
the initial template (1/1250) instead of applying first ALU-PCR.
Quantitative PCR (qPCR) was performed using the FastStart
Universal SYBR Green Master (Roche, Mannheim, Germany) on
a LightCycler 2.0 system (Roche Applied Science, Illinois, USA) or
on a StepOnePlus system (Applied Biosystem, CA, USA).
Species-specific primers were used to amplified human b-actin,
59–TGAGCTGCGTGTGGCTCC–39 and 59–GGCATGGGG-
GAGGGCATACC–39, human p105/50 59–CTGGAAGCAC-
GAATGACAGA–39 and 59–CCTTCTGCTTGCAAATAGGC–
39, RelA/p65 59–CCTGGAGCCAGGCTATCAGTC–39 and
59–CACTGTCACCTGGAAGCAGA–39, c-Rel 59-GAACGAT-
TGGGAAGCAAAAG-39 and 59-GGCACAGTTTCTGGAA-
AAGC-39, human Bfl-1 59-GGCATCATTAACTGGGGAAG-
39 and 59-TCCAGCCAGATTTAGGTTCAA-39, human Bcl2
59-TGTGGATGACTGAGTACCTGAACC-39 and 59-GTTTG-
GGGCAGGCATGTTGAC-39, mouse actin 59–TGGAATC-
CTGTGGCATCCATGAAAC–39 and 59–TAAAACGCAGCT-
CAGTAACAGTCCG–39, HTLV-1 gag 59-CCCTCCAGTTAC-
GATTTCCA-39 and 59–GGCTTGGGTTTGGATGAGTA–39 ,
tax 59–GTTGTATGAGTGATTGGCGGGGTAA–39 and 59–
TGTTTGGAGACTGTGTACAAGGCG–39, hbz 59-GGCAG-
AACGCGACTCAACCG-39 and 59-GCCGATCACGATGCG-
TTTCCC-39; in this later case, PCR amplifications were
conducted on oligo(dT)-primed cDNAs with a forward primer
spanning the HBZ-SI mRNA exon 1 and a reverse primer located
in the exon 2; these primers do not overlap with the splice sites,
avoiding false positive. Amplification of human b-actin was done
for each experimental sample to normalize results in RT-PCR
experiments.
Evaluation of the proviral load
The proviral load was expressed as number of copies of provirus
per 100,000 human cells. It was evaluated by qPCR on genomic
DNA for the number of copies of tax and the number of copies of
human b-actin. To establish the calibration curve we assumed that
one ng of DNA extracted from human PBMC contains 333 copies
of b-actin. TARL-2 is a rat HTLV-1 infected cell line which has a
single copy of HTLV-1 proviral DNA per cell and we therefore
assume that one ng of DNA contains 167 copies of the tax gene
[41].
Cell transfection and plasmids
Human immature thymocytes were obtained as previously
described [12], using the EasySep CD3-positive selection cocktail
to deplete CD3+ cells followed by negative selection using the
human CD4+ T-cell enrichment cocktail (StemCell Technologies
Inc, Vancouver, BC, Canada) according to the manufacturer’s
instructions. The Tax expression plasmid, pCMV-TaxGFP
(generous gift from R. Mahieux), contains the tax coding sequence
in frame with the N-terminal extremity from the gfp sequence
under the control of the cytomegalovirus promoter. pMax-GFP
(Amaxa) was used as a GFP-control expressing vector. Immature
thymocytes (2.106 cells), cultured overnight in a-MEM complete
medium containing 20 ng/ml IL-7 (R&D, Abingdon, UK) and
10 ng/ml SCF (Peprotech, Rocky hill, NJ), were transfected either
with 4 mg of pCMV-TaxGFP or pCMV-GFP by nucleofection
(Human CD34 cell nucleofector kit, Amaxa, Ko¨ln, Germany)
according to the manufacturer’s instructions. Twenty-four hours
later, GFP+ cells were sorted from both cultures using an ARIA
sorter (BD-Beckinson).
Selective amplification and quantification of proviral
insertion sites
DNA was extracted from tissue samples as described in the
section ‘‘DNA and RNA isolation’’ and the selective amplification
and quantification of the proviral insertion sites was done as
previously described [20]. The DNA was sheared by sonication. A
linker containing a tag was ligated, and nested PCR was
performed between the end of the HTLV-1 LTR and the linker.
Nested PCR products were pooled to construct the sequencing
library. A paired-end read (read 1 and read 2) plus a tag index
read were acquired on an Illumina Genome Analyzer II. Read 1
and read 2 were mapped against the human genome (build hg18)
and the proviral insertion site and the shear site were respectively
deduced. The relative abundance (in percent of proviral load) of a
given unique insertion site (UIS) was calculated from the number
of amplicons of different length (i.e. different shear sites). For more
details, see [20].
Statistical analysis
Statistical analyses were performed using the GraphPad Prism
software and the Mann-Whitney U test or the x2 test.
Supporting Information
Figure S1 Distribution of abundance of unique inser-
tion sites in different tissues of the same mouse. The
HTLV-1 clonal structure in each genomic DNA sample is
depicted by a pie chart. Each slice represents one unique insertion
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site (UIS); the size of the slice is proportional to the relative
abundance of that UIS. (A) The 3 most abundant UISs were
colored in blue. These UISs were found neither in the spleen nor
in the lymph node sample. (B, C) The 3 most abundant UISs were
colored in red/orange. 11_82937981 means that the provirus of
this clonal population is inserted in chromosome 11, coordinate
82937981. These 3 major UISs were detected in the thymus but at
a relatively low abundance.
(TIFF)
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